We have also demonstrated that an Oxr1 transgene can delay neurodegeneration in an mouse model of amyotrophic lateral sclerosis (ALS), [13] and over-expressing Oxr1 in mammalian cells can alleviate cellular abnormalities caused by pathogenic ALS-associated mutations [13]. This evidence concerns the gene OXR1 and amyotrophic lateral sclerosis.